Elsevier

Atherosclerosis

Volume 105, Issue 1, January 1994, Pages 79-87
Atherosclerosis

Research paper
Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells

https://doi.org/10.1016/0021-9150(94)90010-8Get rights and content

Abstract

Lipoprotein-proteoglycan (LP-PG) complexes are taken up more avidly by macrophages and smooth muscle cells (SMCs) than native lipoproteins (LPs). The enhanced uptake may contribute to lipid accumulation and foam cell formation during atherogenesis. Endothelial injury is known to alter proteoglycan (PG) synthesis and distribution in the neointima developed in response to injury. The present study examines the uptake and degradation of LP-PG complexes, derived from PG of injured aortas by arterial SMCs. Rabbit apo-B lipoprotein (LP), including VLDL, IDL and LDL was isolated by ultracentrifugation and coupled with PG extracted from normal aortas (NPG) or with PG from injured aortas (IPG). Rabbit aortic SMCs were cultured from intima-media explants, incubated with 125I-LP 125I-LP-NPG or 125I-LP-IPG for 20 h at 37C. LP binding, internalization and degradation were markedly increased (P < 0.001) for LP-NPG and LP-IPG over native LP. Competition experiments indicated that more than 50% of the LP-PG complexes were taken up by the apo-B/E receptor pathway. Phagocytosis was the second important route of uptake of these complexes, whereas the scavenger receptor played a minor part in the uptake and degradation of LP-PG complexes. Data from this study indicate that LP-PG complexes accelerate LP uptake and degradation by SMC more than native LP. Therefore, these complexes may contribute to lipid accumulation by SMC, thus generating foam cells. Furthermore, LP-PG complexes prepared from PG of injured aortas are more effective in lipid accumulation than LP-PG complexes from PG of normal aortas.

References (30)

  • B.G.J. Salisbury et al.

    Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages

    Am. J. Pathol.

    (1985)
  • D. Steinberg et al.

    Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity

    N. Engl. J. Med.

    (1989)
  • M. Aviram

    Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells

    J. Biol. Chem.

    (1992)
  • E. Hurt-Camejo et al.

    Effect of arterial proteoglycan and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells

    Arteriosclerosis Thromb.

    (1992)
  • J.L. Goldstein et al.

    Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

  • Cited by (40)

    • Adipocyte-Derived Versican and Macrophage-Derived Biglycan Control Adipose Tissue Inflammation in Obesity

      2020, Cell Reports
      Citation Excerpt :

      We have now identified this proteoglycan as versican, a large chondroitin sulfate-rich proteoglycan found in the ECM of most soft tissues (Wight, 2002). Versican is elevated during development and inflammation (Kang et al., 2018; Snyder et al., 2015; Wight et al., 2020) and regulates events associated with adipose tissue inflammation, such as lipoprotein retention (Williams and Tabas, 1995, 1998), lipid uptake, and foam cell formation (Ismail et al., 1994; Llorente-Cortés et al., 2002; Srinivasan et al., 1995). Versican also influences inflammatory processes by interacting with chemokines, growth factors, proteases, and receptors such as CD44, PSGL-1, and TLR2 on the surface of immune cells to provide intrinsic signals and influence the immune cell phenotype (Hirose et al., 2001; Taylor and Gallo, 2006; Wu et al., 2005).

    • The P2Y<inf>2</inf> receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells

      2016, Atherosclerosis
      Citation Excerpt :

      Lipoproteins that are retained in the extracellular matrix are taken up by VSMCs and macrophages, which subsequently results in CE accumulation and foam cell formation [6]. Macrophages become foam cells through the uptake of diversely modified LDLs [7], whereas the aggregation of LDLs seems to be a key condition for lipid accumulation in VSMCs [6,8]. Scavenger receptors on macrophages mediate their transformation to foam cells following uptake of modified and oxidized LDLs (oxLDLs).

    • Actions of antioxidants in the protection against atherosclerosis

      2012, Free Radical Biology and Medicine
      Citation Excerpt :

      The oxidative modification hypothesis of atherosclerosis suggests that LDL oxidation initiates disease and that foam cell formation by oxidized LDL represents an early key event in atherogenesis. However, foam cells can arise from LDL modified in ways other than oxidation, such as formation of complexes with proteoglycans [267], indicating that oxidative modification of LDL is not a requirement for atherosclerosis to occur. This notion is concordant with the accumulation of nonoxidized lipids preceding that of oxidized lipids [184] and the fact that several animal studies have dissociated atherosclerosis from arterial lipid oxidation [2].

    • Lipid loading of human vascular smooth muscle cells induces changes in tropoelastin protein levels and physical structure

      2012, Biophysical Journal
      Citation Excerpt :

      The incorporation of matrix-retained LDL by macrophages (16,17) and VSMC (18,19) leads to the accumulation of cholesteryl ester (CE) and formation of foam cells. Macrophages become foam cells through the uptake of diversely modified LDLs, whereas the aggregation of LDLs seems to be a key condition for lipid accumulation in VSMCs (21–23). Aggregated LDLs (agLDLs) obtained by vortexing LDL in vitro share structural characteristics with LDL aggregates present in atherosclerotic lesions (24).

    View all citing articles on Scopus
    View full text